Regression of Achilles tendon xanthomas evaluated by CT scan after hypolipidemic treatment with simvastatin. A case

Genovefa Kolovou1, Deliana Daskalova, Irene Mastorakou

  • 11st Cardiology Department of the Onassis Cardiac Surgery Center, Athens, Greece. g_kolovou@yahoo.co.uk

Angiology
|May 25, 2004
PubMed

Insights

Familial hypercholesterolemia (FH) diagnosis can be improved with computed tomography (CT) to detect Achilles tendon xanthomas (XAT). CT imaging also tracks XAT regression during lipid-lowering drug treatment, aiding cardiovascular risk assessment.

Area of Science:

  • Cardiovascular Medicine
  • Radiology
  • Genetics

Background:

  • Familial hypercholesterolemia (FH) is a common genetic disorder increasing cardiovascular death risk.
  • Clinical diagnosis often relies on tendon xanthomas, but physical detection is subjective.
  • Instrumental methods may offer more sensitive xanthoma evaluation.

Observation:

  • This case study highlights computed tomography (CT) for detecting Achilles tendon xanthomas (XAT).
  • CT visualized XAT in a patient with heterozygous FH.
  • The study monitored XAT regression following hypolipidemic drug therapy.

Findings:

  • Computed tomography (CT) effectively detects Achilles tendon xanthomas (XAT) in FH patients.
  • CT imaging demonstrated regression of XAT with lipid-lowering treatment.
  • XAT behavior may mirror vascular atherosclerotic lesion progression/regression.

Implications:

  • CT offers an objective tool for FH diagnosis and monitoring XAT.
  • This imaging technique can assess treatment efficacy in FH.
  • Understanding XAT progression may provide insights into atherosclerosis.